1 / 12

Separation Systems for Commercial Biotechnology Market Research and Forecast Report 2023-2028

According to the latest research report by IMARC Group, The global separation systems for commercial biotechnology market size reached US$ 25.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 36.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.94% during 2023-2028.<br><br>More Info:- https://www.imarcgroup.com/separation-systems-for-commercial-biotechnology-market

Télécharger la présentation

Separation Systems for Commercial Biotechnology Market Research and Forecast Report 2023-2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Separation Systems for Commercial Biotechnology Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

  2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

  3. Report Description and Highlights Report Description Global Separation Systems for Commercial Biotechnology Market Research Report: The latest report by IMARC, titled “Separation Systems for Commercial Biotechnology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” " finds that the global separation systems for commercial biotechnology market size reached US$ 25.3 Billion in 2022. Separation systems for commercial biotechnology are solutions used to purify and separate biological products from complex mixtures and solutions such as diagnostic reagents, biochemicals, and biopharmaceuticals. It includes various equipment and devices, such as membranes, filters, centrifuges, chromatographs, biochips, and microarrays. These solutions also offer various benefits, such as higher recovery and minimal waste generation. Owing to these properties, separation systems find extensive applications across pharmaceutical, food and beverage (F&B), cosmetic, and agriculture industries. Request Free Sample Report: https://www.imarcgroup.com/separation-systems-for-commercial- biotechnology-market/requestsample

  4. Report Description and Highlights Report Description Global Separation Systems for Commercial Biotechnology Market Trends: The market is primarily driven by the expanding pharmaceutical industry. In addition, the escalating demand for personalized drugs, biopharmaceuticals, and cell-based therapies due to the increasing prevalence of chronic medical ailments represents another major growth-inducing factor. Besides this, various technological advancements, including the development of innovative upstream bioprocessing technologies that eliminate biohazardous by- products using simplified procedures, are contributing to the market growth. Moreover, the improving healthcare infrastructure, especially in developing countries, and extensive research and development (R&D) in the field of biotechnology are also creating a positive market outlook across the globe. Looking forward, IMARC Group expects the market value to reach US$ 36.1 Billion by 2028, exhibiting a CAGR of 5.94% during the forecast period (2023-2028). Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

  5. Report Description and Highlights Report Description Market Summary: Breakup by Methods: • Modern Methods • Microarray • Lab-on-a-Chip • Magnetic Separation • Others • Conventional Methods • Chromatography • Flow Cytometry • Membrane Filtration • Others Breakup by Application: • Pharmaceutical • Vaccines • Proteins • Hormones and Insulin • Enzymes

  6. Report Description and Highlights Report Description • Human Blood Plasma Fractionation • Mammalian Cell Cultures • Food and Cosmetics • Agriculture • Others Breakup by Region: • North America • United States • Canada • Asia-Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany

  7. Report Description and Highlights Report Description • France • United Kingdom • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa

  8. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • • Agilent Technologies Inc. Becton Dickinson and Company Bio-Rad Laboratories Inc. Hitachi Ltd. Merck KGaA Pall Corporation (Danaher Corporation) PerkinElmer Inc. Qiagen N.V Repligen Corporation Sartorius AG Shimadzu Corporation Thermo Fisher Scientific. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/separation-systems-for- commercial-biotechnology-market

  9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

  12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com

More Related